Status
Global HQ
Singapore, Singapore
Countries of investment
Investment stages
Industries
About
MiRXES utilizes RNA technology to provide early, personalized diagnoses aimed at improving health outcomes and reducing cancer mortality through proactive prevention strategies.
MiRXES utilizes RNA technology to provide early, personalized diagnoses aimed at improving health outcomes and reducing cancer mortality through proactive prevention strategies.